Public Employees Retirement System of Ohio Buys New Shares in Zimmer Biomet Holdings, Inc. $ZBH

Public Employees Retirement System of Ohio purchased a new stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in the second quarter, HoldingsChannel reports. The fund purchased 59,934 shares of the medical equipment provider’s stock, valued at approximately $5,160,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of ZBH. BlackRock Inc. bought a new position in shares of Zimmer Biomet during the 2nd quarter worth about $1,344,282,000. Primecap Management Co. CA bought a new stake in shares of Zimmer Biomet in the second quarter valued at about $328,578,000. Norges Bank acquired a new stake in Zimmer Biomet during the fourth quarter worth about $221,234,000. Bank of America Corp DE acquired a new position in Zimmer Biomet in the 2nd quarter valued at approximately $187,480,000. Finally, Franklin Resources Inc. lifted its position in shares of Zimmer Biomet by 43.2% in the 4th quarter. Franklin Resources Inc. now owns 6,685,987 shares of the medical equipment provider’s stock worth $601,204,000 after acquiring an additional 2,017,857 shares during the period. 88.89% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Truist Financial lifted their price objective on Zimmer Biomet from $92.00 to $106.00 and gave the stock a “hold” rating in a report on Thursday, August 6th. Zacks Research raised Zimmer Biomet from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 25th. Weiss Ratings upgraded shares of Zimmer Biomet from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, August 4th. Needham & Company LLC reissued a “hold” rating on shares of Zimmer Biomet in a report on Wednesday, August 5th. Finally, UBS Group restated a “buy” rating and issued a $120.00 price objective on shares of Zimmer Biomet in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, fourteen have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $104.42.

Zimmer Biomet Price Performance

Shares of ZBH stock opened at $99.61 on Thursday. The stock’s fifty day simple moving average is $94.56 and its 200 day simple moving average is $91.58. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.69 and a quick ratio of 0.94. The firm has a market cap of $19.00 billion, a price-to-earnings ratio of 24.24, a P/E/G ratio of 1.88 and a beta of 0.47. Zimmer Biomet Holdings, Inc. has a one year low of $79.12 and a one year high of $106.88.

Zimmer Biomet (NYSE:ZBH) last announced its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $2.01 by $0.06. Zimmer Biomet had a return on equity of 13.12% and a net margin of 9.48%.The firm had revenue of $2.18 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same period in the prior year, the business posted $2.07 earnings per share. The business’s revenue was up 4.8% compared to the same quarter last year. Zimmer Biomet has set its FY 2026 guidance at 8.470-8.590 EPS. On average, analysts expect that Zimmer Biomet Holdings, Inc. will post 8.54 earnings per share for the current fiscal year.

Zimmer Biomet Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $0.96 annualized dividend and a dividend yield of 1.0%. Zimmer Biomet’s dividend payout ratio is presently 23.36%.

Zimmer Biomet Company Profile

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.